Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FKBP1A | P62942 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | CA12 | O43570 | 2/20 | 0.40 |
| ▸ | CA1 | P00915 | 2/20 | 0.40 |
| ▸ | CA2 | P00918 | 2/20 | 0.40 |
| ▸ | CA9 | Q16790 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20599674 | 0.86 | FKBP1A (0.42) | FKBP1AALDH1A1GAATSHRSMN1; SMN2 | |
| SCHEMBL25220996 | 0.77 | ALDH1A1 (0.51) | ALDH1A1SMN1; SMN2NPC1RAB9A | |
| SCHEMBL21088915 | 0.76 | ALDH1A1 (0.51) | FKBP1AALDH1A1GAASMN1; SMN2 | |
| SCHEMBL14979994 | 0.74 | CA1 (0.60) | ALDH1A1GAATSHRHTTSMN1; SMN2 | |
| SCHEMBL18725089 | 0.72 | ALDH1A1 (0.49) | ALDH1A1GAATSHRSMN1; SMN2NPC1 | |
| SCHEMBL20625194 | 0.72 | ALDH1A1 (0.47) | FKBP1AALDH1A1GAATSHRSMN1; SMN2 | |
| SCHEMBL116845 | 0.72 | ALDH1A1 (0.56) | ALDH1A1TSHRSMN1; SMN2NPC1RAB9A | |
| SCHEMBL28371759 | 0.72 | ALDH1A1 (0.56) | ALDH1A1SMN1; SMN2NPC1RAB9A | |
| SCHEMBL621696 | 0.72 | ALDH1A1 (0.56) | ALDH1A1SMN1; SMN2NPC1RAB9A | |
| SCHEMBL20624914 | 0.71 | HPGD (0.42) | FKBP1AALDH1A1GAATSHRSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9938301-B2 | Dihydropyrimido fused ring derivative as HBV inhibitor | QILU PHARMACEUTICAL CO., LTD. (CN) | 2018-04-10 | — | — | US | disclosed |